Hanover reappointed for Lilly public affairs account

Hanover has been reappointed as Lilly's UK public affairs and corporate comms agency following a competitive pitch.

The agency has held the account since 2010 and re-pitched for the business in April, with three other agencies involved in the process. Lilly selected Hanover again based on the strength of their previous work together.

To be led once again by Hanover director Andrew Harrison, the brief encompasses government affairs, public policy, digital and corporate comms functions.

Hanover said it will work to help the pharmaceutical company navigate a changing political landscape, characterised by significant systemic changes for the NHS.

Mr Harrison said: "Lilly UK has been a central and important client to Hanover for the past four years. Their decision to stick with us highlights the strength of our integrated comms and policy approach."

Other pharmaceutical clients of Hanover's include companies such as Celltrion Healthcare, UCB, Amgen, Novo Nordisk and Napp.